# BlossomHill Therapeutics Inc. (BLSM)

Source: https://www.quantisnow.com/company/BLSM
Generated: 2026-11-08T01:38:19.871Z

- Ticker: BLSM
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2026
- SEC CIK: 0001839970

## About

BlossomHill Therapeutics, Inc. is a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop innovative small molecule medicines that address significant unmet medical needs in cancer treatment. Founded and led by industry veteran J. Jean Cui, Ph.D., with her proven track record in oncology drug design and development - including three FDA-approved drugs - BlossomHill Therapeutics applies cutting-edge science with a goal to address key oncogenic drivers and improve patient outcomes in difficult-to-treat cancers. The company's lead clinical program is BH-30643, an investigational, non-covalent, macrocyclic, brain active, mutant-selective OMNI-EGFR inhibitor for the treatment of EGFR-mutant non-small cell lung cancer (NSCLC), which has received Fast Track designation for the C797S resistance population after 3rd generation EGFR TKI treatment.

## Latest BLSM news and filings

- 2026-11-04 12:00 UTC [BlossomHill Therapeutics Announces Upcoming Presentation for BH-30236, an Oral Macrocyclic CLK Inhibitor, at the 68th American Society of Hematology (ASH) Annual Meeting](https://www.quantisnow.com/insight/blossomhill-therapeutics-announces-upcoming-presentation-for-bh-30236-an-oral-macrocyclic-6771184)
- 2026-11-03 12:00 UTC [Conference Announcement] [BlossomHill Therapeutics to Present at Guggenheim’s  3rd Annual Healthcare Innovations Conference](https://www.quantisnow.com/insight/blossomhill-therapeutics-to-present-at-guggenheims-3rd-annual-healthcare-innovations-6768326)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BLSM
- Earnings history: https://www.quantisnow.com/earnings/BLSM
- Dividend history: https://www.quantisnow.com/dividends/BLSM
- Insider transactions: https://www.quantisnow.com/insiders/BLSM
- Options chain: https://www.quantisnow.com/options/BLSM
- SEC 8-K filings only: https://www.quantisnow.com/company/BLSM/8-k
- RSS and alerts for BLSM: https://www.quantisnow.com/docs/rss-feeds.md